Cas:97685-00-2 dabsyl-l-tryptophan manufacturer & supplier

We serve Chemical Name:dabsyl-l-tryptophan CAS:97685-00-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dabsyl-l-tryptophan

Chemical Name:dabsyl-l-tryptophan
CAS.NO:97685-00-2
Synonyms:L-Tryptophan, N-[[4-[(E)-2-[4-(dimethylamino)phenyl]diazenyl]phenyl]sulfonyl]-;Dabsyl-L-tryptophan;4-Dimethylaminoazobenzene-4′-sulfonyl-L-tryptophan;Dbs-Trp-OH;N-[(4-{(E)-[4-(Dimethylamino)phenyl]diazenyl}phenyl)sulfonyl]-L-tryptophan;D1459
Molecular Formula:C25H25N5O4S
Molecular Weight:491.562
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:766.9±70.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.665
PSA:135.60000
Exact Mass:491.162720
LogP:5.42

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like L-Tryptophan, N-[[4-[(E)-2-[4-(dimethylamino)phenyl]diazenyl]phenyl]sulfonyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D1459 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Tryptophan, N-[[4-[(E)-2-[4-(dimethylamino)phenyl]diazenyl]phenyl]sulfonyl]- Use and application,D1459 technical grade,usp/ep/jp grade.


Related News: Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships. dabsyl-l-tryptophan manufacturer In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank. dabsyl-l-tryptophan supplier China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. dabsyl-l-tryptophan vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. dabsyl-l-tryptophan factory The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.